SDGR

Dopo l'orario di chiusura: 23.76

Schrodinger Inc (SDGR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SDGR Giù? Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Schrodinger Inc Stock (SDGR) Company Profile

Schrodinger Inc

Healthcare (1154)

503-299-1150

1540 BROADWAY, NEW YORK, NY

@schrodinger

Prossima data di guadagno

Ultimi documenti SEC

SDGR's Discussions on Twitter

Confronta SDGR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SDGR Schrodinger Inc	23.76	1.91B	193.35M	-177.58M	-172.43M	-2.45
VEEV Veeva Systems Inc	241.20	38.62B	2.75B	714.14M	1.09B	4.33
DOCS Doximity Inc	60.43	11.14B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	68.90	9.03B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	96.99	7.91B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	39.11	7.09B	906.14M	-52.62M	89.62M	-0.3621

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-07-02	Iniziato	Leerink Partners	Outperform
2023-12-05	Iniziato	KeyBanc Capital Markets	Overweight
2023-05-05	Ripresa	Piper Sandler	Overweight
2022-12-19	Iniziato	Goldman	Neutral
2022-03-01	Iniziato	Citigroup	Buy
2021-11-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-11-19	Iniziato	Piper Sandler	Overweight
2021-11-11	Downgrade	BofA Securities	Buy → Neutral
2021-10-13	Iniziato	Berenberg	Buy
2021-09-01	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-05-25	Iniziato	Craig Hallum	Buy
2020-11-23	Aggiornamento	BofA Securities	Neutral → Buy
2020-10-12	Aggiornamento	Jefferies	Hold → Buy
2020-03-02	Iniziato	BMO Capital Markets	Outperform
2020-03-02	Iniziato	Jefferies	Hold
2020-03-02	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Schrodinger Inc Borsa (SDGR) Ultime notizie

Schrodinger Inc Azioni (SDGR) Dati Finanziari

Schrodinger Inc Azioni (SDGR) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Akinsanya Karen	President of R&D, Therapeutics	Apr 14 '25	Sale	25.09	16,723	419,570	15,625

Schrodinger Inc (SDGR)

Schrodinger Inc Stock (SDGR) Company Profile

Confronta SDGR con altri titoli

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Schrodinger Inc Borsa (SDGR) Ultime notizie

Schrödinger, Inc. (NASDAQ:SDGR) Q1 2025 Earnings Call Transcript - Insider Monkey

Schrödinger First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Schrödinger, Inc. Reports Strong Q1 Growth Amid Challenges - TipRanks

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... - Yahoo Finance

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Advancements - GuruFocus

Decoding Schrodinger Inc (SDGR): A Strategic SWOT Insight - GuruFocus

Schrödinger Q1 2025 slides: revenue jumps 63%, clinical readouts on horizon - Investing.com Canada

Schrödinger projects strong 2025 revenue growth with $45M-$50M in drug discovery - MSN

Schrodinger Inc (SDGR) Q1 2025 Earnings: Revenue Surges to $59.6M, Beating Estimates; Net Loss Widens to $59.8M - GuruFocus

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Schrodinger Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Earnings call transcript: Schrodinger Q1 2025 beats EPS expectations, stock rises - Investing.com

Schrodinger (SDGR) Surpasses Revenue Expectations with Strong Gr - GuruFocus

Schrodinger (SDGR) Reaffirms 2025 Financial Projections | SDGR Stock News - GuruFocus

Earnings Flash (SDGR) SCHRODINGER Reports Q1 Revenue $59.6M, vs. FactSet Est of $54.7M - marketscreener.com

Schrodinger earnings beat by $0.10, revenue topped estimates - Investing.com

Schrödinger Reports Strong First Quarter 2025 Financial Results - Eagle-Tribune

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)? - Yahoo Finance

AI Healthcare Boom Gains Speed as Regulators and Innovators Align - Benzinga

Schrödinger to Present at BofA Securities 2025 Healthcare Conference - 01net

Schrödinger to Present at BofA Securities 2025 Healthcare Conference | SDGR Stock News - GuruFocus

Learn to Evaluate (SDGR) using the Charts - news.stocktradersdaily.com

Top 5 AI & Digital Biotech Companies (May 2025) - Securities.io

Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report - ReportAlert

Schrodinger Inc (SDGR) Shares Gap Down to $25.585 on Apr 28 - GuruFocus

Schrödinger, Inc. (NASDAQ:SDGR) Looks Just Right With A 33% Price Jump - simplywall.st

Schrödinger Presents New Preclinical Data at AACR Annual Meeting - 01net

Schrödinger, Inc. (SDGR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential - Insider Monkey

Schrödinger to Announce First Quarter 2025 Financial Results on May 7 | SDGR Stock News - GuruFocus

Schrödinger to Announce First Quarter 2025 Financial Results on May 7 - marketscreener.com

3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - 01net

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus

Schrödinger (NASDAQ:SDGR) shareholders are up 29% this past week, but still in the red over the last five years - simplywall.st

Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last? - MSN

An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 26% Undervalued - Yahoo Finance

Schrodinger price target raised to $32 from $30 at KeyBanc - TipRanks

Schrodinger’s Karen Akinsanya sells $419,570 in stock By Investing.com - Investing.com South Africa

Schrodinger’s Karen Akinsanya sells $419,570 in stock - Investing.com

Schrodinger issues statement on FDA phasing out animal testing requirement - TipRanks

FDA recent move marks paradigm shift in drug development, boosting Schrödinger (SDGR) and other biotech stocks - Investorsobserver

Schrodinger (SDGR) Backs FDA's Initiative to Cut Animal Testing in Drug Development | SDGR Stock News - GuruFocus

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal T - GuruFocus

Schrödinger backs FDA’s move away from animal testing By Investing.com - Investing.com South Africa

Schrodinger to Launch Predictive Toxicology Tool in H2 - marketscreener.com

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs - 01net

Schrodinger Inc Azioni (SDGR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Schrodinger Inc Azioni (SDGR) insider trading

Simile a SDGR